Deep TLR PrimedTM T cells induce potent anti-tumor activity without systemic toxicity

Nathan Westcott, Austin Boesch, Vasily Rybakin, Ji Young Hwang, Kira Jørgensen, Rasmus Lassen, Martin Kræmer, Martin Bak, Gael Veiga, Jonas Bruun, Carlos Tassa, Harrison Rodts, Manny Sequeira, Karsten Sauer, Thomas L. Andresen

Research output: Contribution to conferencePosterResearchpeer-review

81 Downloads (Pure)
Original languageEnglish
Publication date2019
Publication statusPublished - 2019
EventAACR Special Conference on Tumor Immunology and Immunotherapy - Boston Marriott Copley Place, Boston, United States
Duration: 17 Nov 201920 Nov 2019

Conference

ConferenceAACR Special Conference on Tumor Immunology and Immunotherapy
LocationBoston Marriott Copley Place
CountryUnited States
CityBoston
Period17/11/201920/11/2019

Cite this

Westcott, N., Boesch, A., Rybakin, V., Hwang, J. Y., Jørgensen, K., Lassen, R., Kræmer, M., Bak, M., Veiga, G., Bruun, J., Tassa, C., Rodts, H., Sequeira, M., Sauer, K., & Andresen, T. L. (2019). Deep TLR PrimedTM T cells induce potent anti-tumor activity without systemic toxicity. Poster session presented at AACR Special Conference on Tumor Immunology and Immunotherapy, Boston, United States.